User assessment of Norditropin NordiFlex&reg;,a new prefilled growth hormone pen:a Phase IV multicenter prospective study | Zendy

Täuber | Zendy; Jaquet | Zendy; Perelroizen | Zendy; Petruş | Zendy; Bertrand | Zendy; Coutant | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

User assessment of Norditropin NordiFlex®,a new prefilled growth hormone pen:a Phase IV multicenter prospective study

Author(s) -

Täuber,

Jaquet,

Perelroizen,

Petruş,

Bertrand,

Coutant

Publication year - 2013

Publication title -

patient preference and adherence

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.885

H-Index - 48

ISSN - 1177-889X

DOI - 10.2147/ppa.s43460

Subject(s) - medicine , multicenter study , prospective cohort study , growth hormone , pediatrics , hormone , randomized controlled trial

BACKGROUNDAIM: In growth disorders, ensuring long-term growth hormone therapy (GHT) remains a challenge that might compromise the clinical outcome. Consequently, strategies aiming at alleviating the burden of daily injection might improve the treatment benefit. The study reported here was performed to assess the ease of use of Norditropin NordiFlex(®) (Novo Nordisk, Princeton, NJ, USA) compared with that of the devices previously used in children treated with GHT with recombinant somatropin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research